Amy L. Burroughs Terns Pharmaceuticals, Inc. (TERN) insider trading activity

TERN Quotes by TradingView

Amy L. Burroughs is Chief Executive Officer of Terns Pharmaceuticals, Inc.. Currently has a direct ownership of 47,083 shares of TERN, which is worth approximately $178,444. The most recent transaction as insider was on Jun 25, 2025, when has been sold 23,314 shares (Common Stock) at a price of $3.87 per share, resulting in proceeds of $90,225. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 47.1K
146.52% 3M change
n/a 12M change
Total Value Held $178,444

Amy L. Burroughs Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 25 2025
BUY
Open market or private purchase
$90,225 $3.87 p/Share
23,314 Added 33.12%
47,083 Common Stock
Dec 05 2024
BUY
Open market or private purchase
$110,467 $7.15 p/Share
15,450 Added 44.72%
19,099 Common Stock
Nov 30 2024
BUY
Open market or private purchase
$2,606 $5.11 p/Share
510 Added 2.53%
19,609 Common Stock

Also insider at

TNYA
Tenaya Therapeutics, Inc. Healthcare
DMAC
DiaMedica Therapeutics Inc. Healthcare
Director
ALB

Amy L. Burroughs

Chief Executive Officer
Minneapolis, MN

Track Institutional and Insider Activities on TERN

Follow Terns Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TERN shares.

Notify only if

Insider Trading

Get notified when an Terns Pharmaceuticals, Inc. insider buys or sells TERN shares.

Notify only if

News

Receive news related to Terns Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TERN